print gohome
jpost
 
US top court denies Teva stay in Copaxone patent fight
By REUTERS
18/04/2014
 
WASHINGTON - US Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd that would have prevented a lower court ruling from going into effect while the court considers an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitors to go on the market as soon as next month.
print gohome
print
All rights reserved © 1995 - 2012 The Jerusalem Post.